# Kobe University Capital

> Kobe University Capital is a VC fund in Kobe backing Medical, Sales and Health Care. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Kobe, Japan
- Total investments: 11
- Last investment: Jul 2026
- Lead investor: 27%
- Last updated: Aug 2026
- Website: https://kuc.vc

Kobe University Capital is a VC fund in Kobe focused on Medical and Sales. Kobe University Capital is create new indstry academia cllabration and technology transfer models.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1M–$7.1M |
| Series A | $644k–$7.6M |
| Series B | $5.7M–$7.8M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 27% |
| Sales | 2 | 18% |
| Health Care | 2 | 18% |
| Therapeutics | 2 | 18% |
| Biotechnology | 2 | 18% |

20 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 27% |
| Series A | 3 | 27% |
| Series B | 3 | 27% |
| Pre-Seed | 1 | 9% |
| Funding Round | 1 | 9% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Sinumy | Sinumy develops touchless identity authentication technology and high-speed, high-precision position measurement technology. | $3.4M | Seed | Jul 29, 2026 |  |
| SecureNavi | SecureNavi offers automation tools for the information security management system. It reduces conventional analogue operations using excel and word. For inquiries, telephone numbers and physical addresses are available on their website. | $7.8M | Series B | Nov 06, 2025 |  |
| eSep | eSep develops membrane-based separation technology that enables to simplify processes and reduce energy consumption drastically in future chemical and petroleum industries. It develops and offers membrane-based separation technology for easy, eco-efficient separation. | $2.8M |  | Nov 05, 2025 |  |
| TelaAxon | TelaAxon develops artificial intelligence technology for sustainable operations, enhancing human-AI coexistence, safety, and wellness. | $644.4K | Series A | Jan 29, 2025 |  |
| Alpha Fusion | Alpha Fusion produces astatine based radiopharmaceuticals for targeted alpha therapy. | $6.9M | Series B | Oct 08, 2024 |  |
| Pittan | PITTAN is a health tech startup that focuses on the development of high-speed analytical equipment for use in the healthcare industry. The company's primary service is to analyze the internal status of an individual's body to promote beautiful and healthy skin. This is achieved through the application of analytical chemistry.PITTAN's services are designed to provide insights into the body's health, which can be used to inform personal care and wellness decisions. | $1M | Seed | Aug 05, 2024 |  |
| Cyto-Facto | Cyto-Facto is a biotechnology company that develops and manufactures CAR-T cell therapies and mesenchymal stem cell products. | $7.6M | Series A | Apr 22, 2024 |  |
| Hedgehog MedTech | Hedgehog Medtech is a medical firm focused on digital therapeutics (DTx). DTx is a pharmaceutically approved programmable medical device that assists patients' medical operations via smartphone apps. | $3.4M | Series A | Dec 01, 2023 |  |
| TelaAxon | TelaAxon develops artificial intelligence technology for sustainable operations, enhancing human-AI coexistence, safety, and wellness. | $197.8K | Pre-Seed | Nov 13, 2023 |  |
| Tear Exo | Tear Exo is a biotechnology research company that produces and sells liquid biopsy using materials for molecular recognition. | $7.1M | Seed | Aug 04, 2023 |  |

10 of 11 investments shown.

## Co-investors
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund, 5 deals together
- [Miraidoa](https://shizune.co/investors/profile/future-venture-capital) — VC Fund, 4 deals together
- [Kyoto Capital Partners](https://shizune.co/investors/profile/kyoto-capital-partners) — VC Fund, 3 deals together
- [SBI Investment](https://shizune.co/investors/profile/sbi-investment-2) — VC Fund, 3 deals together
- [D3](https://shizune.co/investors/profile/d3-llc) — VC Fund, 2 deals together
- [ITOCHU Technology Ventures](https://shizune.co/investors/profile/itochu-technology-ventures) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Japan](https://shizune.co/investors/biotechnology-investors-japan)
- [Biotechnology VC Funds in Japan](https://shizune.co/investors/biotechnology-vc-funds-japan)
- [Biotech VC Funds in Japan](https://shizune.co/investors/biotech-vc-funds-japan)
- [Manufacturing Investors in Japan](https://shizune.co/investors/manufacturing-investors-japan)
- [Manufacturing VC Funds in Japan](https://shizune.co/investors/manufacturing-vc-funds-japan)
- [Payments Investors in Japan](https://shizune.co/investors/payments-investors-japan)

## FAQ

### What does Kobe University Capital invest in?

Kobe University Capital invests primarily in Medical, Sales and Health Care startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Kobe University Capital's check size?

Kobe University Capital typically joins rounds of $1M–$7.1M at Seed, $644k–$7.6M at Series A and $5.7M–$7.8M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Kobe University Capital participates in.

### When did Kobe University Capital last invest?

The most recent investment recorded for Kobe University Capital closed in Jul 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co